LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinoma
{{output}}
Background: Renal cell carcinoma (RCC) ranks as the second most common urological cancer globally. Despite recent progresses, there is a low survival rate for metastatic RCC that is the consequence of advanced stage diagnosis in ... ...
